Hirotoshi Ishiwatari
Appearances
DateMay 18, 2024INTRODUCTION: In recent years, matched therapy based on comprehensive genomic profiling (CGP) has extended the prognosis of pancreatic cancer patients. Foundation One CDx® (F1CDx) is a representative test of commercially available CGP (CACGP)…Presenter
Speakers
- DateMay 21, 2024INTRODUCTION: Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) has been performed as an alternative drainage to endoscopic retrograde cholangiopancreatography (ERCP) for advanced cancer. However, Peritonitis, which is less likely to occur with ERCP, is observed in 3.6-9.4% after EUS-HGS…
DateMay 18, 2024CONTRAST ENHANCED HARMONIC EUS-GUIDED VERSUS CONVENTIONAL EUS-GUIDED FINE NEEDLE BIOPSY WITH MACROSCOPIC ON-SITE EVALUATION FOR SOLID PANCREATIC LESIONS: A MULTICENTER RANDOMIZED TRIALModerators
University of California San DiegoUniversity of Alabama at Birmingham
